Voyager Therapeutics Inc (VYGR)
Deferred Revenue
$244.00K
Quarterly · Period ending: · USD
VYGR Deferred Revenue
Latest reported$244.00Kperiod ending
Latest reported$244.00Kperiod ending
VYGR Quarterly Deferred Revenue ($0.00 → $244.00K)
Quarterly deferred revenue
High-resolution chart · PNG
VYGR deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 244,000 | |
| 395,000 | |
| 1,590,000 | |
| 10,578,000 | |
| 20,517,000 | |
| 21,095,000 | |
| 24,394,000 | |
| 22,629,000 | |
| 20,516,000 | |
| 51,439,000 | |
| 42,881,000 | |
| 44,261,000 | |
| 31,666,000 | |
| 5,680,000 | |
| 59,377,000 | |
| 56,630,000 | |
| 87,003,000 | |
| 86,994,000 | |
| 33,886,000 | |
| 9,537,000 | |
| 8,069,000 | |
| 6,443,000 | |
| 0 | |
| 13,462,000 | |
| 43,911,000 | |
| 46,923,000 | |
| 47,233,000 | |
| 56,542,000 | |
| 52,291,000 | |
| 44,566,000 | |
| 20,847,000 | |
| 20,250,000 | |
| 19,840,000 | |
| 20,217,000 | |
| 3,380,000 | |
| 9,537,000 | |
| 4,215,000 | |
| 4,914,000 | |
| 6,764,000 | |
| 12,296,000 | |
| 14,257,000 | |
| 18,719,000 | |
| 19,589,000 | |
| 19,589,000 | |
| 19,589,000 | |
| 0 | |
| 0 | |
| 0 |